Skip to content
LinkedInTwitter
  • INVESTORS
  • CAREERS
Outlook Therapeutics Logo
  • ABOUT
    • Overview
    • Senior Leadership
    • Board of Directors
  • PIPELINE
    • ONS-5010 / LYTENAVA™ OVERVIEW
    • ONS-5010 Clinical Progress
    • Unmet Patient Needs
    • Repackaged IV Bevacizumab
    • New Ophthalmic Anti-VEGF
    • Potential First-Line Therapy
  • NEWS
  • CONTACT

ABOUT

Home/ABOUT
ABOUTlavoie@otlk2018-06-07T12:11:26+00:00
Linkedin
© 2018-2023 Outlook Therapeutics, Inc.
Privacy Policy | Disclaimer | Terms of use

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

Accept Cookie Settings
  • About Cookies

    About Cookies

    Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Necessary

    Necessary

    Always Active
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
    Name Domain Purpose Expiry Type
    wpl_user_preference outlooktherapeutics.com WP GDPR Cookie Consent Preferences 1 year HTTP
  • Marketing

    Marketing

    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics

    Analytics

    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
    Name Domain Purpose Expiry Type
    _ga outlooktherapeutics.com Google Universal Analytics long-time unique user tracking identifier. 2 years HTTP
    _gid outlooktherapeutics.com Google Universal Analytics short-time unique user tracking identifier. 1 days HTTP
    _gat outlooktherapeutics.com Google Analytics tracking cookie. Session HTTP
    sc_is_visitor_unique outlooktherapeutics.com StatCounter unique visitor tracking cookie. 2 years HTTP
    is_unique statcounter.com StatCounter unique visitor tracking cookie. 5 years HTTP
  • Preferences

    Preferences

    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified

    Unclassified

    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
    Name Domain Purpose Expiry Type
    is_visitor_unique statcounter.com --- 2 years ---
    _ga_94N37D3KG5 outlooktherapeutics.com --- 2 years ---
Cookie Settings
Go to Top